Marco has an extensive experience in leading biologics development from start-up stage to registration and commercial operations, introducing innovative approaches to process development and business value creation. He has fostered successful partnerships working with groups from different cultural backgrounds and locations around the world.
Prior to joining Novavax in July 2020, Dr. Cacciuttolo served as head of manufacturing at Nosocomial Vaccine Corporation, chief operating officer at PathoVax LLC, and managing director of Batavia Biosciences. Earlier in his career, he held positions of increasing responsibility at MedImmune LLC, Medarex, Percivia LLC and Tetragenetics, Inc.
Dr. Cacciuttolo received a bachelor’s degree in biochemical engineering from Pontifical Catholic University of Valparaíso and a doctorate in biochemical engineering from the University of Maryland, Baltimore.